Inclusion criteria
|
Type I or type II diabetes mellitus |
Clinically significant macular oedema (CSMO)* |
HbA1c ⩽10.0 |
Blood pressure ⩽160/100 mm Hg |
Exclusion criteria
|
Proliferative diabetic retinopathy |
Previous laser photocoagulation for diabetic retinopathy |
Preretinal or vitreous haemorrhage |
Retinal detachment |
Significant media opacities |
Iris neovascularisation |
Previous retinal or intraocular surgery |
Cataract extraction or lens implantation within the past 12 months |
Glaucoma or other ocular disease interfering with assessment of the treatment results |